Z

Zevra Therapeutics Inc
NASDAQ:ZVRA

Watchlist Manager
Zevra Therapeutics Inc
NASDAQ:ZVRA
Watchlist
Price: 8.55 USD -0.81% Market Closed
Market Cap: 467.5m USD

Wall Street
Price Targets

ZVRA Price Targets Summary
Zevra Therapeutics Inc

Wall Street analysts forecast ZVRA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ZVRA is 22.73 USD with a low forecast of 18.18 USD and a high forecast of 26.25 USD.

Lowest
Price Target
18.18 USD
113% Upside
Average
Price Target
22.73 USD
166% Upside
Highest
Price Target
26.25 USD
207% Upside
Zevra Therapeutics Inc Competitors:
Price Targets
IMP
Imexpharm Corp
11% Downside
LQDA
Liquidia Corp
83% Upside
300725
PharmaBlock Sciences Nanjing Inc
21% Upside
AMIORG
Ami Organics Ltd
28% Upside
VY4
SNDL Inc
180% Upside
603456
Zhejiang Jiuzhou Pharmaceutical Co Ltd
13% Upside

Revenue
Forecast

Revenue Estimate
Zevra Therapeutics Inc

The compound annual growth rate of Zevra Therapeutics Inc's revenue for the next 3 years is 120%.

N/A
Past Growth
120%
Estimated Growth
Estimates Accuracy
0%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Zevra Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

Net Income Estimate
Zevra Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-92%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ZVRA's stock price target?
Price Target
22.73 USD

According to Wall Street analysts, the average 1-year price target for ZVRA is 22.73 USD with a low forecast of 18.18 USD and a high forecast of 26.25 USD.

What is Zevra Therapeutics Inc's Revenue forecast?
Projected CAGR
120%

The compound annual growth rate of Zevra Therapeutics Inc's revenue for the next 3 years is 120%.

Back to Top